7 Day Trial
ALL ACCESS PASS
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight buying pressure.
Fate Therapeutics Price Chart Indicators
|Moving Averages||Level||Buy or Sell|
Fate Therapeutics Technical Analysis Indicators
|Chart Indicators||Level||Buy or Sell|
|MACD (12, 26):||-1.85||Sell|
|Relative Strength Index (14 RSI):||38.19||Sell|
|Chaikin Money Flow:||357938||-|
|Bollinger Bands||Level||Buy or Sell|
|Bollinger Bands (25):||(23.11 - 27.99)||Sell|
|Bollinger Bands (100):||(22.37 - 30.97)||Sell|
Fate Therapeutics Technical Analysis
|Technical Analysis: Buy or Sell?|
|MACD (12, 26):|
|Relative Strength Index (14 RSI):|
|Bollinger Bands (25):|
|Bollinger Bands (100):|
Technical Analysis for Fate Therapeutics Stock
Is Fate Therapeutics Stock a Buy?
- Fate Therapeutics share price is 22.34 while FATE 8-day simple moving average is 22.57, which is a Sell signal.
- The stock price of FATE is 22.34 while Fate Therapeutics 20-day SMA is 25.07, which makes it a Sell.
- Fate Therapeutics 50-day simple moving average is 28.69 while FATE share price is 22.34, making it a Sell technically.
- FATE stock price is 22.34 and Fate Therapeutics 200-day simple moving average is 33.51, creating a Sell signal.
FATE Technical Analysis vs Fundamental Analysis
Fate Therapeutics Stock Info
Price in USD:
Fate Therapeutics 52-Week Range
Fate Therapeutics (FATE) is a Sell
Fate Therapeutics Share Price Forecast
What is the Fate Therapeutics stock price today?
The Fate Therapeutics stock price is 22.34 USD today.
Will FATE stock go up or go down?
Fate Therapeutics> share price is forecast to RISE/FALL based on technical indicators
Is Fate Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fate Therapeutics is overvalued.
Is Fate Therapeutics Stock a Buy?
- Fate Therapeutics share price is 22.34 while FATE 8-day exponential moving average is 22.91, which is a Sell signal.
- The stock price of FATE is 22.34 while Fate Therapeutics 20-day EMA is 24.72, which makes it a Sell.
- Fate Therapeutics 50-day exponential moving average is 26.90 while FATE share price is 22.34, making it a Sell technically.
- FATE stock price is 22.34 and Fate Therapeutics 200-day simple moving average is 35.19, creating a Sell signal.
Fundamental Analysis of Fate Therapeutics
Is Fate Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.10 per share, and a decrease next year of $0.54 per share.
Technical Analysis of Fate Therapeutics
Should I short Fate Therapeutics stock?
- FATE Moving Average Covergence Divergence (MACD) indicator is -1.85, suggesting Fate Therapeutics is a Sell
- Fate Therapeutics Relative Strength Index (RSI) is 38.19, which suggest Fate Therapeutics is oversold
- The Bollinger Bands (25) for Fate Therapeutics is (23.11 - 27.99), which suggest Fate Therapeutics is a Sell
- The Bollinger Bands (100) for Fate Therapeutics is (22.37 - 30.97), which suggest Fate Therapeutics is a Sell
* Fate Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.